AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

LifeStance Health Group, Inc.

$12.97 +$6.01 (+86.35%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$13
Day Range
$12.94$13.28
Year Range
$4.77$13.28
Market Cap
5.03B
AVG Volume
4.34M
Trailing/Forward PE
99.62/59.11
PEG ratio
2.72
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2435.35M
26 Q1403.48M
25 Q4382.19M
25 Q3363.81M
25 Q2345.31M
25 Q1332.97M
24 Q4325.48M
24 Q3312.72M
24 Q2312.33M
24 Q1300.44M
Net Income (USD)
-40M-20M020M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q223.61M
26 Q114.24M
25 Q411.67M
25 Q31.08M
25 Q2-3.79M
25 Q1709K
24 Q4-7.11M
24 Q3-5.96M
24 Q2-23.28M
24 Q1-21.1M
Operating Income (USD)
-20M020M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q230.65M
26 Q122.28M
25 Q418.08M
25 Q37.41M
25 Q2-2.95M
25 Q11.6M
24 Q41.06M
24 Q347K
24 Q2-15.95M
24 Q1-16.77M
EBITDA (USD)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q244.34M
26 Q134.87M
25 Q431.51M
25 Q320.94M
25 Q210.96M
25 Q115.36M
24 Q415.19M
24 Q315.15M
24 Q21.8M
24 Q17.73M
Cash Flows (USD)
-50M050M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q287.92M
26 Q122.34M
25 Q482.77M
25 Q317M
25 Q256.64M
25 Q1-10.26M
24 Q456.02M
24 Q317.67M
24 Q238.95M
24 Q1-26.94M
EPS (USD)
-0.1-0.0500.050.124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.06
26 Q10.04
25 Q40.03
25 Q30
25 Q2-0.01
25 Q10
24 Q4-0.02
24 Q3-0.02
24 Q2-0.06
24 Q1-0.06
Expenses (USD)
-50M050M100M150MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2120.13M
26 Q1111.1M
25 Q469.56M
25 Q3105.91M
25 Q2105.13M
25 Q1101.6M
24 Q4100.01M
24 Q390.32M
24 Q2100.26M
24 Q194.04M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2225.94M
26 Q1194.8M
25 Q4248.64M
25 Q3203.9M
25 Q2188.93M
25 Q1134.34M
24 Q4154.57M
24 Q3102.61M
24 Q286.97M
24 Q149.45M
Debt ratios
-10010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.19
26 Q10.01
25 Q4-0.69
25 Q34.32
25 Q25.04
25 Q17.13
24 Q48.29
24 Q327.21
24 Q2-7.61
24 Q1-5.49
Margins
0%10%20%30%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Margins by quarter
PeriodMargins
26 Q235.15%
26 Q133.69%
25 Q433.04%
25 Q332.04%
25 Q231.4%
25 Q132.97%
24 Q433.62%
24 Q332.12%
24 Q231.31%
24 Q131.53%
Return on Capital
-2%-1%0%1%2%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Return on Capital by quarter
PeriodReturn on Capital
26 Q21.6%
26 Q10.96%
25 Q40.77%
25 Q30.07%
25 Q2-0.26%
25 Q10.05%
24 Q4-0.49%
24 Q3-0.41%
24 Q2-1.63%
24 Q1-1.48%
Shares Outstanding
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2383.52M
26 Q1387.26M
25 Q4386.64M
25 Q3386.96M
25 Q2386.73M
25 Q1383.27M
24 Q4379.75M
24 Q3380.36M
24 Q2379.43M
24 Q1376.33M
Book Value Per Share (USD)
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q23.85
26 Q13.82
25 Q43.93
25 Q33.86
25 Q23.81
25 Q13.8
24 Q43.81
24 Q33.78
24 Q23.77
24 Q13.8
Total Assets (USD)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LFST Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q22.18B
26 Q12.15B
25 Q42.2B
25 Q32.15B
25 Q22.15B
25 Q12.1B
24 Q42.12B
24 Q32.11B
24 Q22.12B
24 Q12.11B
Employee Count
05K10K15K20212022202320242025
LFST Employee Count by quarter
PeriodEmployee Count
202510.96K
202410.22K
20239.32K
20227.83K
20216.63K
PE Ratio
0100200300400med 174.96Mar 26Apr 26May 26Jul 26Aug 26Sep 26
LFST PE Ratio by quarter
PeriodPE Ratio
Sep 2698.3
Sep 2696.49
Aug 2693.3
Aug 2694.51
Aug 2694.14
Aug 2682.16
Jul 26174.96
Jul 26181.97
Jul 26193.32
Jul 26178.8
Jul 26188.15
Jun 26171.62
Jun 26149.92
Jun 26141.9
Jun 26123.71
May 26128.72
May 26123.37
May 26127.71
May 26128.55
May 26301.29
Apr 26282.09
Apr 26275.69
Apr 26256.08
Apr 26252.48
Mar 26252.88
Mar 26256.08
Mar 26253.28
Mar 26277.29
Feb 26289.69
Free Cash Flow Yield
-2%0%2%4%6%8%med 4.49%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LFST Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 264.22%
Sep 264.3%
Aug 264.45%
Aug 264.39%
Aug 264.41%
Aug 265.05%
Jul 264.4%
Jul 264.23%
Jul 263.99%
Jul 264.31%
Jul 264.1%
Jun 264.49%
Jun 265.14%
Jun 265.43%
Jun 266.23%
May 265.99%
May 266.25%
May 266.03%
May 265.99%
May 265.02%
Apr 265.36%
Apr 265.49%
Apr 265.91%
Apr 265.99%
Mar 265.98%
Mar 265.91%
Mar 265.97%
Mar 265.45%
Feb 265.22%
Feb 264.32%
Feb 264.39%
Feb 264.52%
Jan 264.36%
Jan 264.2%
Jan 264.26%
Jan 264.17%
Jan 264.43%
Dec 254.33%
Dec 254.38%
Dec 254.47%
Dec 254.76%
Nov 254.75%
Nov 254.79%
Nov 254.82%
Nov 254.91%
Oct 256.34%
Oct 255.97%
Oct 256.16%
Oct 256.15%
Oct 255.63%
Sep 255.73%
Sep 255.94%
Sep 255.94%
Sep 255.78%
Aug 255.67%
Aug 255.59%
Aug 255.71%
Aug 257.1%
Aug 257.05%
Jul 256.45%
Jul 256.33%
Jul 255.92%
Jul 255.58%
Jun 255.19%
Jun 255.53%
Jun 255.08%
Jun 254.57%
May 254.5%
May 254.87%
May 254.57%
May 254.66%
May 253.32%
Apr 253.46%
Apr 253.37%
Apr 253.3%
Apr 253.4%
Mar 253.37%
Mar 253.29%
Mar 253.26%
Mar 252.97%
Feb 252.9%
Feb 251.2%
Feb 251.16%
Feb 251.17%
Jan 251.16%
Jan 251.16%
Jan 251.15%
Jan 251.19%
Jan 251.18%
Dec 241.23%
Dec 241.26%
Dec 241.29%
Dec 241.26%
Nov 241.23%
Nov 241.25%
Nov 241.29%
Nov 241.25%
Nov 24-0.69%
Oct 24-0.68%
Oct 24-0.66%
Price to Sales
1234med 2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LFST Price to Sales by quarter
PeriodPrice to Sales
Sep 263.14
Sep 263.08
Aug 262.98
Aug 263.02
Aug 263.01
Aug 262.62
Jul 262.72
Jul 262.82
Jul 263
Jul 262.77
Jul 262.92
Jun 262.66
Jun 262.33
Jun 262.2
Jun 261.92
May 262
May 261.91
May 261.98
May 261.99
May 262.04
Apr 261.91
Apr 261.87
Apr 261.74
Apr 261.71
Mar 261.72
Mar 261.74
Mar 261.72
Mar 261.88
Feb 261.97
Feb 262.02
Feb 261.99
Feb 261.93
Jan 262
Jan 262.08
Jan 262.05
Jan 262.09
Jan 261.97
Dec 252.02
Dec 251.99
Dec 251.96
Dec 251.83
Nov 251.84
Nov 251.82
Nov 251.81
Nov 251.78
Oct 251.44
Oct 251.53
Oct 251.48
Oct 251.48
Oct 251.62
Sep 251.59
Sep 251.54
Sep 251.54
Sep 251.58
Aug 251.61
Aug 251.63
Aug 251.6
Aug 251.28
Aug 251.13
Jul 251.24
Jul 251.26
Jul 251.35
Jul 251.43
Jun 251.54
Jun 251.44
Jun 251.57
Jun 251.74
May 251.77
May 251.64
May 251.74
May 251.71
May 252.06
Apr 251.98
Apr 252.03
Apr 252.08
Apr 252.02
Mar 252.03
Mar 252.08
Mar 252.1
Mar 252.3
Feb 252.36
Feb 252.43
Feb 252.51
Feb 252.49
Jan 252.51
Jan 252.51
Jan 252.52
Jan 252.44
Jan 252.47
Dec 242.36
Dec 242.3
Dec 242.26
Dec 242.31
Nov 242.37
Nov 242.33
Nov 242.25
Nov 242.32
Nov 242.23
Oct 242.25
Oct 242.32
EV/EBITDA
0100200300med 45.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LFST EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2637.59
Sep 2636.89
Aug 2635.67
Aug 2636.13
Aug 2635.99
Aug 2631.38
Jul 2641.31
Jul 2642.96
Jul 2645.64
Jul 2642.21
Jul 2644.42
Jun 2640.52
Jun 2635.4
Jun 2633.5
Jun 2629.21
May 2630.39
May 2629.13
May 2630.16
May 2630.35
May 2636.26
Apr 2633.91
Apr 2633.12
Apr 2630.72
Apr 2630.28
Mar 2630.33
Mar 2630.72
Mar 2630.38
Mar 2633.32
Feb 2634.84
Feb 2648.62
Feb 2647.87
Feb 2646.64
Jan 2648.12
Jan 2649.8
Jan 2649.24
Jan 2650.17
Jan 2647.44
Dec 2548.49
Dec 2548
Dec 2547.13
Dec 2544.47
Nov 2544.59
Nov 2544.22
Nov 2543.97
Nov 2543.29
Oct 2538.48
Oct 2540.53
Oct 2539.44
Oct 2539.5
Oct 2542.64
Sep 2542.03
Sep 2540.73
Sep 2540.73
Sep 2541.69
Aug 2542.44
Aug 2542.92
Aug 2542.17
Aug 2534.86
Aug 2537.71
Jul 2540.54
Jul 2541.18
Jul 2543.52
Jul 2545.78
Jun 2548.69
Jun 2546.1
Jun 2549.57
Jun 2554.25
May 2555.06
May 2551.43
May 2554.25
May 2553.37
May 2573.06
Apr 2570.49
Apr 2572.1
Apr 2573.44
Apr 2571.53
Mar 2572.1
Mar 2573.53
Mar 2574.2
Mar 2580.58
Feb 2582.49
Feb 25234.72
Feb 25242
Feb 25240.38
Jan 25242
Jan 25242
Jan 25242.54
Jan 25235.53
Jan 25238.49
Dec 24229.06
Dec 24223.67
Dec 24220.44
Dec 24225.02
Nov 24229.87
Nov 24226.64
Nov 24219.63
Nov 24225.56
Aug 21241.93
Jul 21235.43
Jul 21223.67
Price/Operating Cashflow
050100150200med 18.31Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LFST Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2622.83
Sep 2622.41
Aug 2621.67
Aug 2621.95
Aug 2621.86
Aug 2619.08
Jul 2622.26
Jul 2623.15
Jul 2624.59
Jul 2622.75
Jul 2623.93
Jun 2621.83
Jun 2619.07
Jun 2618.05
Jun 2615.74
May 2616.37
May 2615.69
May 2616.25
May 2616.35
May 2619.92
Apr 2618.65
Apr 2618.23
Apr 2616.93
Apr 2616.69
Mar 2616.72
Mar 2616.93
Mar 2616.75
Mar 2618.33
Feb 2619.15
Feb 2618.33
Feb 2618.03
Feb 2617.51
Jan 2618.13
Jan 2618.82
Jan 2618.59
Jan 2618.98
Jan 2617.85
Dec 2518.28
Dec 2518.08
Dec 2517.72
Dec 2516.62
Nov 2516.67
Nov 2516.51
Nov 2516.41
Nov 2516.13
Oct 2512.95
Oct 2513.74
Oct 2513.32
Oct 2513.35
Oct 2514.56
Sep 2514.32
Sep 2513.82
Sep 2513.82
Sep 2514.19
Aug 2514.48
Aug 2514.67
Aug 2514.38
Aug 2511.55
Aug 2511.53
Jul 2512.59
Jul 2512.84
Jul 2513.72
Jul 2514.57
Jun 2515.66
Jun 2514.69
Jun 2516
Jun 2517.76
May 2518.07
May 2516.7
May 2517.76
May 2517.43
May 2524.08
Apr 2523.12
Apr 2523.72
Apr 2524.22
Apr 2523.51
Mar 2523.72
Mar 2524.25
Mar 2524.5
Mar 2526.87
Feb 2527.58
Feb 2547.44
Feb 2549.1
Feb 2548.73
Jan 2549.1
Jan 2549.1
Jan 2549.22
Jan 2547.62
Jan 2548.3
Dec 2446.14
Dec 2444.91
Dec 2444.17
Dec 2445.22
Nov 2446.33
Nov 2445.59
Nov 2443.99
Nov 2445.34
Nov 24189.13
Oct 24190.24
Oct 24196.35
Price to Book
01234med 1.81Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LFST Price to Book by quarter
PeriodPrice to Book
Sep 263.37
Sep 263.31
Aug 263.2
Aug 263.24
Aug 263.22
Aug 262.81
Jul 262.75
Jul 262.86
Jul 263.04
Jul 262.81
Jul 262.95
Jun 262.69
Jun 262.35
Jun 262.23
Jun 261.94
May 262.02
May 261.94
May 262.01
May 262.02
May 261.91
Apr 261.79
Apr 261.75
Apr 261.63
Apr 261.6
Mar 261.61
Mar 261.63
Mar 261.61
Mar 261.76
Feb 261.84
Feb 261.85
Feb 261.82
Feb 261.77
Jan 261.83
Jan 261.9
Jan 261.88
Jan 261.92
Jan 261.8
Dec 251.85
Dec 251.83
Dec 251.79
Dec 251.68
Nov 251.68
Nov 251.67
Nov 251.66
Nov 251.63
Oct 251.29
Oct 251.36
Oct 251.32
Oct 251.33
Oct 251.45
Sep 251.42
Sep 251.37
Sep 251.37
Sep 251.41
Aug 251.44
Aug 251.46
Aug 251.43
Aug 251.15
Aug 251
Jul 251.09
Jul 251.11
Jul 251.19
Jul 251.26
Jun 251.35
Jun 251.27
Jun 251.38
Jun 251.54
May 251.56
May 251.44
May 251.54
May 251.51
May 251.79
Apr 251.71
Apr 251.76
Apr 251.8
Apr 251.74
Mar 251.76
Mar 251.8
Mar 251.82
Mar 251.99
Feb 252.05
Feb 252.04
Feb 252.11
Feb 252.09
Jan 252.11
Jan 252.11
Jan 252.11
Jan 252.05
Jan 252.08
Dec 241.98
Dec 241.93
Dec 241.9
Dec 241.94
Nov 241.99
Nov 241.96
Nov 241.89
Nov 241.95
Nov 241.81
Oct 241.82
Oct 241.88
LifeStance Health Group, Inc.
LFST
Stockpicker

Video analysis: LFST

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LFST

Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)

defenseworld.net · 11 Sep 2026

Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)

LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Insider and Institutional Ownership 85.5% of LifeStance Health

Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy

zacks.com · 10 Sep 2026

Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy

Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.

5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes

zacks.com · 10 Sep 2026

5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes

Rising oil prices and inflation worries shift the spotlight to five low-leverage stocks, with strong earnings growth & balance sheets.

LifeStance Health Group Announces Pricing of Secondary Public Offering

globenewswire.com · 9 Sep 2026

LifeStance Health Group Announces Pricing of Secondary Public Offering

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 22,250,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $12.35 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

LifeStance Health Group Announces Launch of Secondary Public Offering

globenewswire.com · 9 Sep 2026

LifeStance Health Group Announces Launch of Secondary Public Offering

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 22,250,000 shares of LifeStance's common stock, par value $0.01 per share (the “Common Stock”).

LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?

zacks.com · 3 Sep 2026

LifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

LifeStance to Present at Upcoming Investor Conferences

globenewswire.com · 1 Sep 2026

LifeStance to Present at Upcoming Investor Conferences

SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences.

Canada Pension Plan Investment Board Makes New Investment in LifeStance Health Group, Inc. $LFST

defenseworld.net · 1 Sep 2026

Canada Pension Plan Investment Board Makes New Investment in LifeStance Health Group, Inc. $LFST

Canada Pension Plan Investment Board acquired a new stake in shares of LifeStance Health Group, Inc. (NASDAQ: LFST) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 149,000 shares of the company's stock, valued at approximately $1,596,000. Other institutional investors have also

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.